MB4031 - Extras - Viral Subversion of Apoptotic Enzymes

Viruses employ a variety of intricate strategies to inhibit host apoptotic mechanisms, thereby prolonging cell viability and ensuring successful replication and survival. Central to the programmed process of apoptosis are proteases known as caspases, which play critical roles in the execution of cell death. These enzymes therefore represent prime targets for viral interference. Four primary classes of viral inhibitors have evolved to specifically antagonize caspase function: serpins, p35 family members, inhibitors of apoptosis proteins (IAPs), and viral FLICE-inhibitory proteins (vFLIPs). Interestingly, while the majority of viruses primarily aim to suppress apoptosis to evade host immunity and enhance their replication cycles, some viruses have developed the ability to utilize caspases for critical cellular functions, such as the maturation of viral proteins or the release of new virions. This unique duality underscores the complex relationship between viruses and the cellular machinery governing apoptosis.

Apoptosis Mechanisms

Apoptosis is characterized by a series of controlled cellular changes leading to ordered fragmentation of the cell, a process crucial for maintaining tissue homeostasis and eliminating damaged or dangerous cells. Key components of the apoptosis pathway include:

  • Caspases: Cysteine-dependent aspartate-specific proteases that serve as the primary executors of cell death by cleaving specific substrates, thereby driving the apoptotic process to completion.

  • Death-Induced Signaling Complex (DISC): A multi-protein complex necessary for the activation of caspases, triggered by the ligation of death receptors on the cell surface. Apoptosis can originate via two primary pathways:

    • Extrinsic Pathway: Initiated by the binding of extracellular ligands (such as TNF and Fas) to their respective death receptors, culminating in the recruitment and activation of initiator caspases (caspase-8 and caspase-10) at the DISC.

    • Intrinsic Pathway: Triggered by intracellular signals, such as oxidative stress or DNA damage, which lead to the release of cytochrome c from mitochondria. Cytochrome c then binds to Apaf-1, resulting in the formation of the apoptosome, which activates caspase-9, subsequently leading to the activation of effector caspases (-3, -6, and -7) and the execution of apoptosis.

Viral Mechanisms of Caspase Inhibition

Viruses have developed numerous sophisticated mechanisms to evade the apoptotic processes by targeting both the activation and functionality of caspases. This includes:

Serpins

Cytokine Response Modifier A (CrmA) is the prototypic serpin discovered in cowpox virus, capable of inhibiting multiple caspases such as caspase-1 and -8 through a unique mechanism involving conformational change. This leads to the formation of a stable, inactive complex with caspases. The structure of CrmA allows for a selective interaction with these proteases, exemplified by the insertion of its reactive site loop (RSL) into the active site of the caspase, thereby obstructing its enzymatic activity. Other viral serpins, including SPI-1 and SPI-2, exhibit similar inhibitory capabilities.

p35 Family of Inhibitors

p35 proteins, derived from baculoviruses, showcase broad-spectrum caspase inhibition. Their mechanism functions as a suicide inhibitor, binding covalently and inactivating the proteases, similar to serpins, yet employs a slightly different tactic involving thioester linkages and resulting conformational alterations to prevent caspase activation.

Inhibitors of Apoptosis Proteins (IAPs)

Viral IAPs (vIAPs) directly bind to caspases or promote their degradation via proteasomal pathways. While they effectively block access to executioner caspases, they generally lack the ability to engage the initiator caspases; instead, they function as decoy molecules, preventing the action of IAP antagonists, like SMAC/DIABLO, which would otherwise exacerbate apoptosis by neutralizing cellular IAPs. This dynamic interaction enhances the efficacy of IAPs in suppressing apoptosis and fostering viral survival.

Viral FLICE-Inhibitory Proteins (vFLIPs)

vFLIPs are encoded by a diverse array of viruses and play a critical role in interfering with the formation of the DISC. By displacing or inhibiting procaspases from the death receptor complex, vFLIPs prevent the subsequent activation of caspases - specifically caspase-8 and -10 - thereby thwarting the apoptotic response initiated by extrinsic signals.

Interaction with Serine Proteases

In addition to targeting caspases, viruses also target serine proteases involved in apoptotic signaling. For instance, Granzyme B, which is released from cytotoxic T cells, can be inhibited by viral proteins such as CrmA, thus preventing apoptosis in infected cells. Conversely, granzyme H, a host response, demonstrates the ability to counteract viral inhibition by cleaving viral proteins, such as Ad5-100K, akin to granzyme knockdown strategies employed to manage viral infections.

Functional Duality of Caspases

The role of caspases is not solely limited to the initiation of apoptosis. Some viruses capitalize on caspase activity to facilitate critical features of their replication cycle. For example, the Aleutian mink disease virus (ADV) requires caspase activity for essential replication processes, thereby illustrating a nuanced interaction between viral life cycles and apoptotic pathways.

Conclusion

The intricate interplay between the various viral strategies employed to inhibit apoptosis and the cellular mechanisms in place to combat these strategies exemplifies the complex co-evolution of host and viral dynamics. Ongoing research into these interactions has the potential to uncover novel therapeutic approaches for diseases where apoptosis plays a pivotal role, indicating that a comprehensive understanding of viral modulators could facilitate valuable insights applicable to clinical settings aimed at treating or combating viral infections.